Everest Organics Ltd

NSE: EVERESTO · BSE: 524790 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹242.00
Market cap: ₹235.0 Cr
Revenue (annual): ₹196.2 Cr
Net profit (annual): ₹5.55 Cr
P/E (TTM): 44.7×Sector 47.3×
Promoter holding: 59.60%+0.02% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 2 Board Meeting Date 2 Management Change 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

14 Aug 2026 16:24 IST BSE

Financial Results

Everest Organics Q1 FY27 Results: Net Profit ₹1.1 Cr, Down 21.4% YoY

Everest Organics Ltd reported revenue from operations of ₹48.4 Cr (-10.0% YoY) and net profit of ₹1.1 Cr (-21.4% YoY) for Q1 FY27.

Key figure: Net profit ₹1.1 Cr · -21.4% YoY

Open full results → Read the filing ↗

29 May 2026 21:05 IST BSE

Financial Results

Everest Organics Q4 FY26 Results: Net Profit ₹2.6 Cr, Down 10.3% YoY

Everest Organics Ltd reported revenue from operations of ₹48.7 Cr (+19.1% YoY) and net profit of ₹2.6 Cr (-10.3% YoY) for Q4 FY26.

Key figure: Net profit ₹2.6 Cr · -10.3% YoY

Open full results → Read the filing ↗

29 May 2026 21:05 IST BSE

Financial Results

Everest Organics Financial Results

Everest Organics reported annual revenue of ₹196.16 Crore for FY2026. The board also appointed Mr. Narra Venkata Ramana as Chairman and Independent Director.

Value: ₹196.2 Cr

Read the filing ↗

7 Apr 2026 16:18 IST BSE

Financial Results

Everest Organics Q3 FY26 Results: Net Profit ₹0.4 Cr, Down 63.6% YoY

Everest Organics Ltd reported net profit of ₹0.4 Cr (-63.6% YoY) for Q3 FY26.

Key figure: Net profit ₹0.4 Cr · -63.6% YoY

Open full results → Read the filing ↗